Article
Methylation and ovarian cancer: Can DNA methylation be of diagnostic use? (Review)
11 Jan 2019
Abstract excerpt
Ovarian cancer is a silent killer and, due to late diagnosis and frequent chemo resistance in patients, the primary cause of fatality amongst the various types of gynecological cancer. The discovery of a specific and sensitive biomarker for ovarian cancer could improve early diagnosis, thereby saving lives. Biomarkers could also improve treatment, by predicting which patients will benefit from specific treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
